Paradoxical metastatic progression following 3Â months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

The data are consistent with the failure of 3 month NAS to prevent the progression of sub-clinical metastatic deposits already present before treatment.